Skip to main content
. 2020 Jul 21;59(22):2849–2855. doi: 10.2169/internalmedicine.5159-20

Figure 2.

Figure 2.

The baseline serum cytokine levels and the ratio of CCL4/MIP-1β (CCL4) to periostin in responders and non-responders to mepolizumab therapy. The baseline serum cytokine levels and the ratios are shown for responders (circles) and non-responders (squares) to mepolizumab therapy. Bars represent the mean±SEM. *p<0.05.